A CRA expert provided an opinion on damages in patent litigation concerning intellectual property used in a vaccine for porcine viruses. CRA’s reasonable royalty opinion, on behalf of the defendant animal health company, was based in large part upon the payment terms of an existing license previously granted by the plaintiff.
Recent Trends in Rule 702 Decisions
In this CRA Insights, we update the Rule 702 Decision trends in last year’s Insights with 2022 data. We also provide three examples of specific challenges in...